bladerun, I would expect that Merck will look at their preliminary results for the following indications before getting out the check book: Breast cancer Endometrial cancer Prostate cancer Non-small cell lung cancer Sarcomas (Japan) Other solid tumors Pediatrics I would...wouldn't you??